These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1445973)

  • 1. Impaired activity of natural killer cells in patients with acute brucellosis.
    Salmerón I; Rodríguez-Zapata M; Salmerón O; Manzano L; Vaquer S; Alvarez-Mon M
    Clin Infect Dis; 1992 Nov; 15(5):764-70. PubMed ID: 1445973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional impairment of natural killer cells in active ulcerative colitis: reversion of the defective natural killer activity by interleukin 2.
    Manzano L; Alvarez-Mon M; Abreu L; Antonio Vargas J; de la Morena E; Corugedo F; Duràntez A
    Gut; 1992 Feb; 33(2):246-51. PubMed ID: 1541421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy is associated with a reduction in the pattern of the cytotoxic activity displayed by lymphokine-activated killer cells.
    Salméron OJ; Vaquer S; Salmerón I; Moltó L; Lapeña P; Manzano L; de las Heros JI; Alvarez-Mon M
    Am J Reprod Immunol; 1991 Dec; 26(4):150-5. PubMed ID: 1840730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-alpha-2b enhances the natural killer activity of patients with transitional cell carcinoma of the bladder.
    Carballido JA; Moltó LM; Manzano L; Olivier C; Salmerón OJ; Alvarez de Mon M
    Cancer; 1993 Sep; 72(5):1743-8. PubMed ID: 8348503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective natural immunity: an early manifestation of human immunodeficiency virus infection.
    Ullum H; Gøtzsche PC; Victor J; Dickmeiss E; Skinhøj P; Pedersen BK
    J Exp Med; 1995 Sep; 182(3):789-99. PubMed ID: 7650485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. IV. Interleukin-1 deficiency, gamma-interferon deficiency and the restorative effects of short-term culture in the presence of interleukin-2 on natural killer cytotoxicity, natural killer-target binding and production of natural killer cytotoxic factor.
    Chang WC; Hsiao MH; Pattengale PK
    Nat Immun Cell Growth Regul; 1991; 10(2):57-70. PubMed ID: 1881400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
    Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
    J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diminished natural killer activity in pregnancy: modulation by interleukin 2 and interferon gamma.
    Vaquer S; de la Hera A; Jordá J; Martínez C; Escudero M; Alvarez-Mon M
    Scand J Immunol; 1987 Dec; 26(6):691-8. PubMed ID: 3122313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Augmentation of cytotoxic activity by combination with interleukin 2 and interferon gamma].
    Tsunoda T; Tanimura H; Yamaue H; Tani M; Iwahashi M
    Nihon Gan Chiryo Gakkai Shi; 1990 Jun; 25(6):1110-8. PubMed ID: 2118938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer and natural killer-like cell activity of peripheral blood and intrathyroidal mononuclear cells from patients with Graves' disease.
    Tezuka H; Eguchi K; Fukuda T; Otsubo T; Kawabe Y; Ueki Y; Matsunaga M; Shimomura C; Nakao H; Ishikawa N
    J Clin Endocrinol Metab; 1988 Apr; 66(4):702-7. PubMed ID: 3257969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative and functional studies of impaired natural killer (NK) cells in patients with myelofibrosis, essential thrombocythemia, and polycythemia vera. I. A potential role for platelet-derived growth factor in defective NK cytotoxicity.
    Gersuk GM; Carmel R; Pattamakom S; Challita PM; Rabinowitz AP; Pattengale PK
    Nat Immun; 1993; 12(3):136-51. PubMed ID: 8329837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulating effects in vitro of interleukin-2 and interferon-gamma on human blood and bone marrow mononuclear cells.
    Kedar E; Rezai AR; Giorgi JV; Gale RP; Champlin RE; Mitsuyasu RT; Fahey JL
    Nat Immun Cell Growth Regul; 1988; 7(1):13-30. PubMed ID: 2896298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of responsiveness to interferon-gamma but not to interleukin 2 and depressed recycling as natural killer cell abnormalities in childhood lymphohistiocytic syndrome.
    Yang FC; Yabuhara A; Koike K
    Int J Hematol; 1994 Jun; 59(4):273-80. PubMed ID: 8086621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depressed natural killer cell activity in acute myocardial infarction.
    Klarlund K; Pedersen BK; Theander TG; Andersen V
    Clin Exp Immunol; 1987 Oct; 70(1):209-16. PubMed ID: 3500813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation of cytotoxic activity by combination with interleukin 2 and interferon gamma.
    Tsunoda T; Tanimura H; Yamaue H; Iwahashi M; Tani M; Tamai M; Noguchi K; Arii K; Hotta T
    Nihon Geka Hokan; 1991 Nov; 60(6):396-405. PubMed ID: 1820012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer cell activity and cytokine production as prognostic factors in adult acute leukemia.
    Tajima F; Kawatani T; Endo A; Kawasaki H
    Leukemia; 1996 Mar; 10(3):478-82. PubMed ID: 8642865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-candidial activity of natural killer (NK) and lymphokine activated killer (LAK) lymphocytes in vitro.
    Gülay Z; Imir T
    Immunobiology; 1996 Jul; 195(2):220-30. PubMed ID: 8877398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decrease of lymphokine (interleukin-2)-activated killer activity in peripheral blood after administration of natural interferon-gamma.
    Yanagawa H; Sone S; Okubo A; Fukuta K; Nishioka Y; Ogura T
    Jpn J Clin Oncol; 1990 Dec; 20(4):356-63. PubMed ID: 2126575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
    Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
    J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depressed lymphokine-activated killer activity and analysis of the precursor cells in peripheral blood of patients with hepatocellular carcinoma.
    Shirai M; Watanabe S; Nishioka M
    Hepatogastroenterology; 1990 Oct; 37(5):465-8. PubMed ID: 2174825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.